I-37

CAS No. 2359690-13-2

I-37( Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-6-(1-methylcyclopropyl)-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]- )

Catalog No. M22551 CAS No. 2359690-13-2

I-37 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 272 In Stock
10MG 408 In Stock
25MG 735 In Stock
50MG 1103 In Stock
100MG 1654 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    I-37
  • Note
    Research use only, not for human use.
  • Brief Description
    I-37 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.
  • Description
    I-37 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-6-(1-methylcyclopropyl)-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]-
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    SOS1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2359690-13-2
  • Formula Weight
    416.45
  • Molecular Formula
    C22H23F3N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.RAMHARTER JUERGEN,et al.Novel benzylamino substituted pyridopyrimidinone and derivative as SOS1 inhibitor.TW 201938557 A
molnova catalog
related products
  • Belvarafenib

    Belvarafenib (HM95573, GDC5573) is a novel potent, selective RAF inhibitor.

  • PLX-8394

    A potent and selective Raf inhibitor with biochemical IC50 of 3.8/14/23 nM for BRaf V600E/BRAF/CRAF, respectively.

  • BGB-283

    BGB-283 (Lifirafenib, BGB283) is a potent pan RAF inhibitor of BRAF V600E, wt BRAF, CRAFY340/341D and wt ARAF (IC50=5-40 nM).